TransCode Therapeutics, Inc. (RNAZ) Free Cash Flow by Year
TransCode Therapeutics, Inc. recorded an outflow of $19.5M in free cash flow in fiscal year 2025. This represents a decrease of 46.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters TransCode Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RNAZ Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RNAZ Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More TransCode Therapeutics, Inc. financials
Frequently Asked Questions
What was TransCode Therapeutics, Inc.'s free cash flow in fiscal year 2025?
TransCode Therapeutics, Inc. recorded an outflow of $19.5M in free cash flow in fiscal year 2025.
How fast is TransCode Therapeutics, Inc.'s free cash flow growing?
TransCode Therapeutics, Inc. (RNAZ) free cash flow fell by 46.2% year over year, from -$13.4M to -$19.5M in fiscal year 2025.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what TransCode Therapeutics, Inc. (RNAZ) reported on that line in every period on record.